| id | C00003454 |
|---|---|
| Name | Mezerein |
| CAS RN | 34807-41-5 |
| Standard InChI | InChI=1S/C38H38O10/c1-21(2)36-30(44-27(40)18-12-11-15-24-13-7-5-8-14-24)23(4)37-26-19-22(3)29(41)35(26,43)33(42)34(20-39)31(45-34)28(37)32(36)46-38(47-36,48-37)25-16-9-6-10-17-25/h5-19,23,26,28,30-33,39,42-43H,1,20H2,2-4H3/b15-11+,18-12+/t23-,26-,28+,30-,31+,32-,33-,34+,35-,36+,37+,38?/m1/s1 |
| Standard InChI (Main Layer) | InChI=1S/C38H38O10/c1-21(2)36-30(44-27(40)18-12-11-15-24-13-7-5-8-14-24)23(4)37-26-19-22(3)29(41)35(26,43)33(42)34(20-39)31(45-34)28(37)32(36)46-38(47-36,48-37)25-16-9-6-10-17-25/h5-19,23,26,28,30-33,39,42-43H,1,20H2,2-4H3 |
| Phytochemical cluster | No. 41 |
|---|---|
| KCF-S cluster | No. 401 |
| By standard InChI | CHEMBL126750 |
|---|---|
| By standard InChI Main Layer | CHEMBL126750 CHEMBL1468786 CHEMBL2007127 |
| By LinkDB | C09134 |
|---|
| By CAS RN | C011309 |
|---|
| class name | count |
|---|---|
| rosids | 1 |
| family name | count |
|---|---|
| Thymelaeaceae | 1 |
| KNApSAcK organism | *ID | *family | *plant class | *kingdom |
|---|---|---|---|---|
| Daphne mezereum | 66680 | Thymelaeaceae | rosids | Viridiplantae |
| accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
|---|---|---|---|---|---|
| Q99700 | Ataxin-2 | Unclassified protein | CHEMBL1468786 |
CHEMBL2114784
(1)
|
1 / 1 |
| P37840 | Alpha-synuclein | Unclassified protein | CHEMBL1468786 |
CHEMBL2354282
(1)
|
4 / 2 |
| P17405 | Sphingomyelin phosphodiesterase | Enzyme | CHEMBL1468786 |
CHEMBL1794495
(1)
|
2 / 2 |
| P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | CHEMBL1468786 |
CHEMBL2114788
(1)
|
0 / 0 |
| P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | CHEMBL1468786 |
CHEMBL2114810
(1)
|
7 / 3 |
| P11021 | 78 kDa glucose-regulated protein | Unclassified protein | CHEMBL126750 CHEMBL1468786 |
CHEMBL1963893
(2)
|
0 / 0 |
| Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | CHEMBL126750 |
CHEMBL2114827
(1)
CHEMBL2114929
(1)
|
0 / 0 |
| O75164 | Lysine-specific demethylase 4A | Enzyme | CHEMBL1468786 |
CHEMBL1737991
(1)
|
0 / 0 |
| P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | CHEMBL126750 |
CHEMBL1614211
(1)
|
0 / 0 |
| Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | CHEMBL1468786 |
CHEMBL1738184
(1)
|
0 / 0 |
| Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | CHEMBL126750 |
CHEMBL1614364
(1)
|
1 / 1 |
| O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | CHEMBL1468786 |
CHEMBL2354311
(1)
|
1 / 0 |
| Q8IUX4 | DNA dC->dU-editing enzyme APOBEC-3F | Enzyme | CHEMBL1468786 |
CHEMBL1963966
(1)
|
0 / 0 |
| P01215 | Glycoprotein hormones alpha chain | Unclassified protein | CHEMBL1468786 |
CHEMBL2114913
(1)
|
0 / 3 |
| compound | gene | gene name | gene description | interaction | interaction type | form |
reference
pmid |
|---|---|---|---|---|---|---|---|
| C011309 | 142 |
PARP1
ADPRT ADPRT_1 ADPRT1 ARTD1 PARP PARP-1 PPOL pADPRT-1 |
poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) | 3-aminobenzamide inhibits the reaction [mezerein results in increased activity of PARP1 protein] |
decreases reaction
/ increases activity |
protein |
2120135
|
| C011309 | 142 |
PARP1
ADPRT ADPRT_1 ADPRT1 ARTD1 PARP PARP-1 PPOL pADPRT-1 |
poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) | mezerein results in increased activity of PARP1 protein |
increases activity
|
protein |
2120135
2126186 |
| C011309 | 5578 |
PRKCA
AAG6 PKC-alpha PKCA PRKACA |
protein kinase C, alpha (EC:2.7.11.13) | [bryostatin 1 co-treated with mezerein] results in decreased expression of PRKCA protein |
affects cotreatment
/ decreases expression |
protein |
8892972
|
| C011309 | 5579 |
PRKCB
PKC-beta PKCB PRKCB1 PRKCB2 |
protein kinase C, beta (EC:2.7.11.13) | [bryostatin 1 co-treated with mezerein] results in decreased expression of PRKCB protein |
affects cotreatment
/ decreases expression |
protein |
8892972
|
| C011309 | 5579 |
PRKCB
PKC-beta PKCB PRKCB1 PRKCB2 |
protein kinase C, beta (EC:2.7.11.13) | [bryostatin 1 co-treated with mezerein] results in decreased expression of PRKCB protein alternative form |
affects cotreatment
/ decreases expression |
protein |
8892972
|
| C011309 | 5582 |
PRKCG
PKC-gamma PKCC PKCG SCA14 |
protein kinase C, gamma (EC:2.7.11.13) | [bryostatin 1 co-treated with mezerein] results in decreased expression of PRKCG protein |
affects cotreatment
/ decreases expression |
protein |
8892972
|
| OMIM | preferred title | UniProt |
|---|---|---|
| #219080 | Acth-independent macronodular adrenal hyperplasia; aimah |
P63092
|
| #127750 | Dementia, lewy body; dlb |
P37840
|
| #137800 | Glioma susceptibility 1; glm1 |
O75874
|
| #174800 | Mccune-albright syndrome; mas |
P63092
|
| #257200 | Niemann-pick disease, type a |
P17405
|
| #607616 | Niemann-pick disease, type b |
P17405
|
| #166350 | Osseous heteroplasia, progressive; poh |
P63092
|
| #168601 | Parkinson disease 1, autosomal dominant; park1 |
P37840
|
| #605543 | Parkinson disease 4, autosomal dominant; park4 |
P37840
|
| #168600 | Parkinson disease, late-onset; pd |
P37840
|
| #102200 | Pituitary adenoma, growth hormone-secreting |
P63092
|
| #103580 | Pseudohypoparathyroidism, type ia; php1a |
P63092
|
| #603233 | Pseudohypoparathyroidism, type ib; php1b |
P63092
|
| #612462 | Pseudohypoparathyroidism, type ic; php1c |
P63092
|
| #183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
| #607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
| KEGG | disease name | UniProt |
|---|---|---|
| H00081 | Hashimoto's thyroiditis |
P01215
(marker)
|
| H00082 | Graves' disease |
P01215
(marker)
|
| H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P01215
(marker)
|
| H00137 | Niemann-Pick disease (NPD) typeA and B |
P17405
(related)
|
| H00424 | Defects in the degradation of sphingomyelin |
P17405
(related)
|
| H00057 | Parkinson's disease (PD) |
P37840
(related)
|
| H00066 | Lewy body dementia (LBD) |
P37840
(related)
|
| H00244 | Pseudohypoparathyroidism |
P63092
(related)
|
| H00441 | Progressive osseous heteroplasia (POH) |
P63092
(related)
|
| H00501 | Fibrous dysplasia, polyostotic |
P63092
(related)
|
| H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
Q9NUW8 (related) |
| MeSH disease | OMIM | compound | disease name | evidence type |
reference
pmid |
|---|---|---|---|---|---|
| D002471 | C011309 | Cell Transformation, Neoplastic |
marker/mechanism
|
8243401
|
|
| D010212 | C011309 | Papilloma |
marker/mechanism
|
12065085
|
|
| D012878 | C011309 | Skin Neoplasms |
marker/mechanism
|
3098411
12065085 |